Icon

MAVENCLAD (nda022561)- (10MG)

CLADRIBINE EMD SERONO INC
10MG
Yes No
2038-Nov-23 Expired
None 2022-Mar-29
None No
MAVENCLAD is a purine antimetabolite indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults.
0 0 0
Total Other Developers 3
Drugs with Suitability No
10MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.